N. Majidova Et Al. , "Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study.," Biomolecules & biomedicine , vol.24, pp.1776-1784, 2024
Majidova, N. Et Al. 2024. Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study.. Biomolecules & biomedicine , vol.24 , 1776-1784.
Majidova, N., Seyyar, M., Bayraktar, D. I., Dinç, G., İsgandarov, E., Huseynov, J., ... Yaşar, A.(2024). Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study.. Biomolecules & biomedicine , vol.24, 1776-1784.
Majidova, Nargiz Et Al. "Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study.," Biomolecules & biomedicine , vol.24, 1776-1784, 2024
Majidova, Nargiz Et Al. "Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study.." Biomolecules & biomedicine , vol.24, pp.1776-1784, 2024
Majidova, N. Et Al. (2024) . "Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study.." Biomolecules & biomedicine , vol.24, pp.1776-1784.
@article{article, author={Nargiz Majidova Et Al. }, title={Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study.}, journal={Biomolecules & biomedicine}, year=2024, pages={1776-1784} }